Even though mutations that disrupt KEAP-NRF2 interactions contribute to NRF2 activation in human and rodent HCC [56,57], NRF2 activation in HCC can also occur by other mechanisms such as elevated expression of p62 [58]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.